AAAAAA

   
Results: 1-16 |
Results: 16
HIV-RELATED SKIN DISEASES CLEAR WITH COMBINATION THERAPY
Authors: CONANT MA
Citation: Ma. Conant, HIV-RELATED SKIN DISEASES CLEAR WITH COMBINATION THERAPY, Western journal of medicine, 169(4), 1998, pp. 225-226
REDUCTION OF KAPOSIS-SARCOMA LESIONS FOLLOWING TREATMENT OF AIDS WITHRITONOVIR
Authors: CONANT MA OPP KM PORETZ D MILLS RG
Citation: Ma. Conant et al., REDUCTION OF KAPOSIS-SARCOMA LESIONS FOLLOWING TREATMENT OF AIDS WITHRITONOVIR, AIDS, 11(10), 1997, pp. 1300-1301
GENITAL HERPES RECURRENCE - STRESS AND PERSONALITY AS PREDICTORS
Authors: COHEN F KEMENY ME KEARNEY KA ZEGANS LS CONANT MA NEUHAUS JM
Citation: F. Cohen et al., GENITAL HERPES RECURRENCE - STRESS AND PERSONALITY AS PREDICTORS, Psychosomatic medicine, 59(1), 1997, pp. 106-106
ANONYMOUS HIV TESTING USING HOME COLLECTION AND TELEMEDICINE COUNSELING - A MULTICENTER EVALUATION
Authors: FRANK AP WANDELL MG HEADINGS MD CONANT MA WOODY GE MICHEL C
Citation: Ap. Frank et al., ANONYMOUS HIV TESTING USING HOME COLLECTION AND TELEMEDICINE COUNSELING - A MULTICENTER EVALUATION, Archives of internal medicine, 157(3), 1997, pp. 309-314
SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELL MM(3) - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (VOL 8, PG 279, 1995)/
Authors: GOLDSTEIN G CONANT MA BEALL G GROSSMAN HA GALPIN JE BLICK G CALABRESE LH HIRSCH RL FISHER A STAMPONE P MEYERSON LA
Citation: G. Goldstein et al., SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELL MM(3) - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (VOL 8, PG 279, 1995)/, Journal of acquired immune deficiency syndromes and human retrovirology, 11(3), 1996, pp. 315-315
FUNGAL-INFECTIONS IN IMMUNOCOMPROMISED INDIVIDUALS
Authors: CONANT MA
Citation: Ma. Conant, FUNGAL-INFECTIONS IN IMMUNOCOMPROMISED INDIVIDUALS, Dermatologic clinics, 14(1), 1996, pp. 155
GENITAL HERPES - AN INTEGRATED APPROACH TO MANAGEMENT
Authors: CONANT MA BERGER TG COATES TJ LONGO DJ ROBINSON JK DRAKE LA
Citation: Ma. Conant et al., GENITAL HERPES - AN INTEGRATED APPROACH TO MANAGEMENT, Journal of the American Academy of Dermatology, 35(4), 1996, pp. 601-605
RANDOMIZED TRIAL OF MNRGP120 HIV-1 VACCINE IN SYMPTOMLESS HIV-1 INFECTION
Authors: ERON JJ ASHBY MA GIORDANO MF CHERNOW M REITER WM DEEKS SG LAVELLE JP CONANT MA YANGCO BG PATE PG TORRES RA MITSUYASU RT TWADDELL T
Citation: Jj. Eron et al., RANDOMIZED TRIAL OF MNRGP120 HIV-1 VACCINE IN SYMPTOMLESS HIV-1 INFECTION, Lancet, 348(9041), 1996, pp. 1547-1551
SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELLS MM3 - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL/
Authors: GOLDSTEIN G CONANT MA BEALL G GROSSMAN HA GALPIN JE BLICK G CALABRESE LH HIRSCH RL FISHER A STAMPONE P MEYERSON LA
Citation: G. Goldstein et al., SAFETY AND EFFICACY OF THYMOPENTIN IN ZIDOVUDINE (AZT)-TREATED ASYMPTOMATIC HIV-INFECTED SUBJECTS WITH 200-500 CD4 CELLS MM3 - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL/, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 279-288
ITRACONAZOLE THERAPY FOR HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED EOSINOPHILIC FOLLICULITIS
Authors: BERGER TG HEON V SCHULZE K CONANT MA
Citation: Tg. Berger et al., ITRACONAZOLE THERAPY FOR HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED EOSINOPHILIC FOLLICULITIS, Archives of dermatology, 131(3), 1995, pp. 358-360
SAFETY AND IMMUNOGENICITY OF MN AND IIIB RGP120 HIV-1 VACCINES IN HIV-1-INFECTED SUBJECTS WITH CD4 COUNTS GREATER-THAN-500 CELLS/MM(3)/
Authors: ALLAN JD MITSUYASU R LAVELLE JP CONANT MA TWADDELL T KAHN JO
Citation: Jd. Allan et al., SAFETY AND IMMUNOGENICITY OF MN AND IIIB RGP120 HIV-1 VACCINES IN HIV-1-INFECTED SUBJECTS WITH CD4 COUNTS GREATER-THAN-500 CELLS/MM(3)/, AIDS research and human retroviruses, 10, 1994, pp. 190000157-190000157
THE AIDS EPIDEMIC
Authors: CONANT MA
Citation: Ma. Conant, THE AIDS EPIDEMIC, Journal of the American Academy of Dermatology, 31(3), 1994, pp. 190000047-190000050
CONTINUOUS 5-YEAR TREATMENT OF PATIENTS WITH FREQUENTLY RECURRING GENITAL HERPES-SIMPLEX VIRUS-INFECTION WITH ACYCLOVIR
Authors: GOLDBERG LH KAUFMAN RH KURTZ TO CONANT MA ERON LJ BATENHORST RL BOONE GS
Citation: Lh. Goldberg et al., CONTINUOUS 5-YEAR TREATMENT OF PATIENTS WITH FREQUENTLY RECURRING GENITAL HERPES-SIMPLEX VIRUS-INFECTION WITH ACYCLOVIR, Journal of medical virology, 1993, pp. 45-50
OIL POLLUTION ACT OF 1990 - OFFSHORE OIL-SPILLS, THE TANKER BUSINESS,AND THE REGULATION OF POLLUTION-CONTROL
Authors: ANASTASION S KINDT JW SHEEHAN D FARROW S CONANT MA
Citation: S. Anastasion et al., OIL POLLUTION ACT OF 1990 - OFFSHORE OIL-SPILLS, THE TANKER BUSINESS,AND THE REGULATION OF POLLUTION-CONTROL, Marine Technology Society journal, 27(1), 1993, pp. 68-75
LONG-TERM SUPPRESSION OF RECURRENT GENITAL HERPES WITH ACYCLOVIR - A 5-YEAR BENCHMARK
Authors: GOLDBERG LH KAUFMAN R KURTZ TO CONANT MA ERON LJ BATENHORST RL BOONE GS
Citation: Lh. Goldberg et al., LONG-TERM SUPPRESSION OF RECURRENT GENITAL HERPES WITH ACYCLOVIR - A 5-YEAR BENCHMARK, Archives of dermatology, 129(5), 1993, pp. 582-587
THE PRIZE - THE EPIC QUEST FOR OIL, MONEY, AND POWER - YERGIN,D
Authors: CONANT MA
Citation: Ma. Conant, THE PRIZE - THE EPIC QUEST FOR OIL, MONEY, AND POWER - YERGIN,D, The American historical review, 98(3), 1993, pp. 839-840
Risultati: 1-16 |